​

Funding Round

Series B - Vitara Biomedical

Series B - Vitara Biomedical

Investment Firm

Overview

Vitara Biomedical develops a therapeutic platform to support premature infants.

Announced Date

Sep 13, 2022

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Sands Capital Ventures

Sands Capital Ventures

Sands Capital Ventures is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

8

Investor Name
Participant InvestorFlerie Invest
Participant InvestorSands Capital Ventures
Participant InvestorMartin Varsavsky
Participant InvestorGoogle Ventures
Participant InvestorKhosla Ventures

Round Details and Background

Vitara Biomedical raised $75000000 on 2022-09-13 in Series B

Vitara Biomedical develops a therapeutic platform to support premature infants.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 02, 2022
Venture Round - Vitara Biomedical
1-40.0M
Sep 13, 2022
Series B - Vitara Biomedical
8-75.0M

Recent Activity

There is no recent news or activity for this profile.